Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
(Q34634936)
scientific article
scientific article
Language:
Current Data About
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
other details
description | scientific article |
External Links
(P356) |
10.1016/S0140-6736(11)61873-4
|
(P698) |
22226517
|
(P8608) |
release_qbanc4ib25dyrd5q3ni4p57rey
|